baber/WOPTO huggingface dataset:
Patent NZ-306570-A (NZ)
Title: Non-contact radio frequency credit card reading and blacklist checking
Inventor: LEE HO YUN
IPC: G06Q20/40
Filed: 1996-04-29
Abstract: A non-contacting type radio frequency recognizing credit card system is disclosed. In the conventional credit card system, the card recognition is carried out by contactingly inserting a credit card (40) into a card reader which is connected to a card managing company. Therefore, the card may be damaged, and the card recognition time is extended. The non-contacting type radio frequency recognizing credit card system according to the present invention includes: an RF card (40) for being activated by receiving radio frequency from a card terminal (70) so as to transmit its own card number to the card terminal through a radio frequency; the card terminal radiating a radio frequency to induce an electric generation in the RF card, and the card terminal transmitting a card number data (received through a radio frequency) to a wire-connected terminal computer (80); and the terminal computer reading the card number data from the card terminal to make an inquiry into a black list, to make a decision for issuing an approval of a transaction or a denying of the transaction, and to transmit the result of the decision to the card terminal.
Patent NZ-306665-A (NZ)
Title: Tricyclic compounds useful for inhibition of g-protein function and for treatment of prolifeative diseases
Inventor: AFONSO ADRIANO
IPC: A61K31/495
Filed: 1996-04-03
Abstract: he present invention relates to tricyclic compounds of formula 1 for inhibition of abnormal growth cells where: A and B are independently selected from H, halo, or C1-6 alkyl Z is N or CH W is CH, CH2, O or S wherein the dotted line to W represents a double bond which is present when W is CH X is C, CH or N, wherein the dotted line connecting X to the tricyclic ring system represents a double bond when X is C R2 is selected from H, -C(O)OR6- C(O)NR6R7, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, substituted C1-8 alkyl and others R1 is selected from the following groups 1a-d or disulphide dimers thereof or Group 2, Group 3a or 3b, and other groups as defined in the specification
Patent NZ-315156-A (NZ)
Title: Multi-part dispenser comprises an elongate flexible housing having disc, a dispensing nozzle and collar
Inventor: KNOX GARY
IPC: B65D81/32
Filed: 1996-07-23
Abstract: A two or more part dispenser is provided having an elongated flexible housing which defines an interior chamber. A disc(s) is contained within the chamber and is movable from a closed to an open position. In its closed position, the disc(s) divides the chamber into two or more subchambers, each of which contains a different liquid. A collar is slidably mounted to the housing and coaxially disposed around each disc to maintain the disc in its closed position. Upon displacement of the collar away from the disc, a finger on the collar compresses the housing an displaces the disc to its open position thus allowing the two or more liquids in the subchambers to intermix together. A dispensing nozzle assembly having an outlet is fluidly connected by a fluid passageway to the housing chamber. A normally closed valve is positioned in series with this passageway so that, when the valve is moved to its open position, liquid within the housing chamber is dispensed out through the nozzle outlet.
Patent NZ-321517-A (NZ)
Title: Method for waste treatment comprising mixing the waste with a binder, pelletizing the mixture and then kiln incinerating the mixture
Inventor: JONES IAN
IPC: F23G5/20
Filed: 1996-11-08
Abstract: A method for treating waste material comprising mixing the waste material with a firable binder; pelletizing the mixture; coating the pellets with a contact binder coating and a refractory coating and then firing the coated pellets is claimed. The contact binder is hydrate silicates, organic resin binder or ball clay and the refractory coating is refractory clays having a substantial aluminum silicates content, china clays and aluminum silicate.
Patent NZ-330312-A (NZ)
Title: Calcium complex and a process of making a food fortified with calcium
Inventor: REDDY SEKHAR
IPC: A23L21/10
Filed: 1998-04-29
Abstract: A complex, a fortified foodstuff containing a fortifying amount of the complex formed by the interaction of a soluble calcium salt and an alkali metal citrate and a process for its preparation by forming the complex and adding the complex to the foodstuff or forming the complex in the foodstuff is claimed.  The soluble calcium salt may be calcium lactate and the alkali metal citrate may be potassium citrate.  The foodstuff may be a dairy based product, a confectionery product, ice cream or a beverage.  A source of glucuronic acid, e.g. gum arabic, may be added to stabilise the complex.
Patent NZ-332053-A (NZ)
Title: Digital wireless communication between an appliance and a computer system
Inventor: GHORI AMAR
IPC: H04N5/44
Filed: 1998-01-30
Abstract: n appliance is incorporated into a computer system by communicatively coupling the appliance unit to the computer using first and second digital wireless transceivers that are respectively coupled to the appliance unit and the computer system. The transceiver 490 is coupled to the appliance unit through a control unit 492 that includes a decompression engine to decompress signals received across the wireless communication link and a compression engine to compress signals to be transmitted across the wireless communication link.  An output display is presented on the display screen of the appliance unit based on the first signals transmitted from the personal computer405 via the wireless communication link.
Patent NZ-336612-A (NZ)
Title: Cloning using donor nuclei from proliferating somatic cells
Inventor: STICE STEVEN L
IPC: A61K35/12
Filed: 1998-01-05
Abstract: A method of nuclear transfer involving the transplantation of donor differentiated cell nuclei into enucleated oocytes of the same species as the donor cell is provided. The resultant nuclear transfer units are useful for multiplication of genotypes and transgenic genotypes by the production of fetuses and offspring, and for production of isogenic CICM cells, including human isogenic embryonic or stem cells. Production of genetically engineered or transgenic mammalian embryos, fetuses and offspring is facilitated by the present method since the differentiated cell source of the donor nuclei can be genetically modified and clonally propagated.
Patent NZ-336822-A (NZ)
Title: Incontinence pants comprising a waist opening with elastic encased in air-cell material
Inventor: PRATT JENNIFER MARGARET
IPC: A61F13/56
Filed: 1999-08-23
Abstract: Incontinence pants of a waterproof material include a gathered waist opening comprising elastic encased in an air-cell material.  The air-cell material extends down about 10cm from the top edge of the pants where it is joined to the waterproof material comprising the body of the pants.  Gathered leg openings are bound with a soft material.
Patent NZ-501627-A (NZ)
Title: 3,5-dioxo-2(3H)-triazine derivatives substituted by 4-(phenylmethyl)phenyl useful as IL-5 inhibitors
Inventor: FREYNE EDDY JEAN EDGARD
IPC: A61K31/53
Filed: 1998-07-02
Abstract: A triazine derivative or a N-oxide, a pharmaceutically acceptable addition salt or a stereochemically isomeric form thereof has the formula I' wherein: p is 0, 1, 2, 3 or 4; q is 0, 1, 2, 3, 4 or 5; R1 is hydrogen, alkyl, mono or di(alkyl) aminoalkyloxy, mercapto, alkylthio, cycloalkyl, aryl or alkyl substituted with mono or di(alkyl)amino, alkyloxy, aryl or Het; R2 is -C(=X)-Y-R5; X is O or S; Y is a direct bond; R5 is Het; each R3 and R4 are independently halo, haloalkyl, alkyl, hydroxy, alkyloxy, alkylcarbonyloxy, mercapto, alkylthio, alkylsulphonyl, alkylsulphinyl, haloalkylsulphonyl, aryl, cyano, nitro, amino, mono or di(alkyl)amino or (alkylcarbonyl)amino; aryl is optionally substituted phenyl and Het is optionally substituted pyrrolyl, pyrrolinyl, imidazolyl, imidazolinyl, pyrazolyl, pyrazolinyl, triazolyl, tetrazolyl, furanyl, tetrahydrofuranyl, thienyl, thiolanyl, dioxolanyl, oxazolyl, oxazolinyl, isoxazolyl, thiazolyl, thiazolinyl, isothiazolyl, thiadiazolyl, oxadiazolyl, pyridinyl, pyrimidinyl, pyrazinyl, pyranyl, pyridazinyl, morpholinyl, thiomorpholinyl, dioxanyl, dithianyl, trithianyl, triazinyl, benzothienyl, isobenzothienyl, benzofuranyl, isobenzofuranyl, benzthiazolyl, benzoxazolyl, indolyl, isoindolyl, indolinyl, purinyl, benzimidazolyl, quinolyl, isoquinolyl, cinnolinyl, phtalazinyl, quinazolinyl, quinoxalinyl or thiazolopyridinyl. A pharmaceutical composition thereof is useful for treating eosinophil-dependent inflammatory diseases. The compound defined above can also be used to mark or identify a receptor by radiolabeling the compound, administering the compound to biological material and detecting emissions from the compound.
Patent NZ-505280-A (NZ)
Title: Substituted 11-phenyl-dibenzazepine compounds useful for the treatment of diseases characterised by abnormal cell proliferation
Inventor: MOUSSA ADEL M
IPC: A61P17/02
Filed: 1998-11-20
Abstract: Described are substituted 11-phenyl-dibenzazepine compounds of formula (I), which are specific, potent and safe inhibitors of mammalian cell proliferation.  The compounds can be used to inhibit mammalian cell proliferation in situ as a therapeutic approach to the treatment or prevention of diseases characterised by abnormal cell proliferation, such as cancer. R1 is -R', (C6-C20) aryl or substituted (C6-C20) aryl; R2 is -R', -OR', -SR', halogen or trihalomethyl; R3 is -R', -OR', -SR', halogen or trihalomethyl or, when taken together with R4, is (C6-C20) aryleno; R4 is -R', -OR', -SR', halogen or trihalomethyl or, when taken together with R3, is (C6-C20) aryleno; Each of R5, R6, R7, R8, R9, R10, R11, R12, R13 and R14 is independently selected from the group consisting of-R', halogen and trihalomethyl; R15 is -R", -C(O)R", -C(S)R", -C(O)OR", -C(S)OR", -C(O)SR", -C(S)SR", -C(O)N(R")2, -C(O)C(O)R", -C(S)C(O)R", -C(O)C(S)R", -C(S)C(S)R", -C(O)C(O)OR", -C(S)C(O)OR", -C(O)C(S)OR", -C(O)C(O)SR", -C(S)C(S)OR", -C(S)C(O)SR", -C(O)C(S)SR", -C(S)C(S)SR", -C(O)C(O)N(R")2, -C(S)C(O)N(R")2, -C(O)C(S)N(R")2 or -C(S)C(S)N(R")2; each R' is independently selected from the group consisting of -H, (C1-C6) alkyl, (C1-C6) alkenyl and (C1-C6) alkynyl; each R" is independently selected from the group consisting of -H, (C1-C6) alkyl, (C1-C6) alkenyl, (C1-C6) alkynyl, (C6-C20) aryl, (C6-C20) substituted aryl, (C6-C26) alkaryl and substituted (C6-C26) alkaryl; and the aryl and alkaryl substituents are each independently selected from the group consisting of -CN, -OR', -SR', -NO2, -NR'R', halogen, (C1-C6) alkyl, (C1-C6) alkenyl, (C1-C6) alkynyl and trihalomethyl; with the proviso that i) at least one of R1-R15 is other than H, ii) when R1-R7 and R9-R15 are H, then R8 is other than Cl, and iii) when R1, R5 and R6-R15 are H, then R2, R3 and R4 are not -OCH3 at the same time.
Patent NZ-516259-A (NZ)
Title: New mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance
Inventor: HERTOGS KURT
IPC: G01N33/50
Filed: 2000-05-25
Abstract: A computer system directed by software wherein the software correlates (i) the presence of at least one first mutation chosen from 88E, 101H, 101N, 101P, 101Q, 101T, 103H, 103S, 179I, 179E, 181V, 190E, 190S, 190T or the combination of 103R and 179D in an HIV reverse transcriptase and resistance of at least one strain of HIV to at least one no-nucleoside reverse transcriptase inhibitor and (ii) the presence of at least one second mutation chosen form 69S-[S-S], 184G, 184L, 215V, 44D, 44A or 118I in an HIV reverse transcriptase and resistance of at least on strain of HIV to at least one nucleoside reverse transcriptase inhibitor. Also described is a method for evaluating the effectiveness of an antiviral therapy of an HIV-infected patient comprising (i) determining whether a sample collected from an HIV infected patient comprises at least one nucleic acid chosen from: (a) a first nucleic acid encoding a HIV reverse transcriptase having at least one mutation chosen from 88E, 101H, 101N, 101P, 101Q, 101T, 103H, 103S, 179I, 179E, 181V, 190E, 190S, 190T and the combination of mutations 103R and 179D in which the presence of the mutation correlates with resistance to at least one NNRTI; (b) a second nucleic acid encoding a HIV reverse transcriptase having at least one mutation chosen from 69S-[S-S], 184G, 184L, 215V, 44D, 44A or 118I, in which the presence of the mutation correlates with resistance to at least one NNRTI; and (c) a third nucleic acid encoding a HIV protease having at least mutation chosen from 88T and the combination of mutations 33F and 9m in which the presence of at least one mutation correlates with resistance to at least one PI; and (ii) using the presence of the nucleic acid to evaluate the effectiveness of the antiviral therapy. Methods for designing therapy for treating a patient infected with HIV, identifying drugs effective against PI resistant strains of HIV and determining drug sensitivity are described.
Patent NZ-517142-A (NZ)
Title: Bioavailable dosage form of isotretinoin
Inventor: PANT ABHA
IPC: A61K31/07
Filed: 2001-04-09
Abstract: A bioavailable capsule formulation of 13-cis vitamin A acid, the formulation comprising: i) A medicament paste of 13-cis vitamin A acid and a carrier, the carrier having a particle size of less than 300 mm and surface area of between 0.05 - 0.3 m2/g. ii) A suspending agent and other pharmaceutically acceptable excipients.
Patent NZ-519480-A (NZ)
Title: Calcilytic compounds
Inventor: LAGO AMPARO M
IPC: A61P3/14
Filed: 2001-01-24
Abstract: The application discloses the following compounds; 3-{4-Cyano-3- [R-2-hydroxy-3 (2-indan-2-yl-1, 1-dimethyl-ethylamino)-propoxy]-phenyl}-propionic ethyl ester; 3-{4-Cyano-3- [R-2-hydroxy-3 (2-indan-2-yl-1, 1-dimethyl-ethylamino)-propoxy]-phenyl}-propionic acid; 3-{4-Cyano-3- [R-2-hydroxy-3 (2-indan-2-yl-1, 1-dimethyl-ethylamino)-propoxy]-phenyl}-propionic acid isopropyl ester; 3-{4-Cyano-3-[R-2-hydroxy-3(2-indan-2-yl-1,1-dimethyl-ethylamino)-propoxy]-phenyl}-propionic acid 2-ethoxy ethyl ester; 3-{4-Cyano-3- [R-2-hydroxy-3 (2-indan-2-yl-dimethyl-ethylamino)-propoxy]-phenyl}-propionic acid 2-methoxy-1-mthyl-ethyl ester; 3-{4-Cyano-3- {(R)-3[1,1-dimethyl-2- (5,6,7,8-tetrahydro-napthalen-2-yl)-ethylamino]-2-hyroxy-propoxy}-phenyl)-propionic acid; 3-{4-Cyano-3- {(R)-3[1,1-dimethyl-2- (5,6,7,8-tetrahydro-napthalen-2-yl)-ethylamino]-2-hyroxy-propoxy}-phenyl)-propionic acid ethyl ester; 3-{3-Cyano-3- {(R)-3[1,1-dimethyl-2- (5,6,7,8-tetrahydro-napthalen-2-yl)-ethylamino]-2-hyroxy-propoxy}-phenyl)-propionic acid; 3-{3-Cyano-3- {(R)-3[1,1-dimethyl-2- (5,6,7,8-tetrahydro-napthalen-2-yl)-ethylamino]-2-hyroxy-propoxy}-phenyl)-propionic acid ethyl ester; 3-{4-Cyano-3- [(R) -2-hyroxy-3- (2-indan-5-yl-1, 1-dimethyl-ethylamino)-propoxy]-phenyl}-propionic acid; and 3-{4-Cyano-3- [(R) -2-hyroxy-3- (2-indan-5-yl-1, 1-dimethyl-ethylamino)-propoxy]-phenyl}-propionate ethyl ester; pharmaceutically acceptable salts of these compounds are also claimed. These compounds can be used in the manufacture of pharmaceuticals for the treatment of abnormal bone or mineral homeostasis including, periodontal disease, osteoarthritis, Paget's disease and humoral hypercalcemia.
Patent NZ-521452-A (NZ)
Title: Method of constructing structures useful as roads and building scaffolds on slopes
Inventor: FUKUI TOMIO
IPC: E01D21/00
Filed: 2001-03-23
Abstract: Method of constructing structures useful as roads and building scaffolds on slopes without cutting slopes and without damaging mountainous areas, comprising the steps of: 1) dropping at least two vertical ropes along a slope; 2) joining the vertical ropes by a set of upper and lower horizontal ropes, at a predetermined spaced interval; 3) joining these horizontal ropes to bar-like base structures; 4) erecting at least one pillar on the first base structure joined to the lower rope; 5) and placing and fixing plate-shaped structures on the second base structure joined to the upper horizontal rope and joined on the pillar or pillars.
Patent NZ-522345-A (NZ)
Title: Confectionery product with a casing and a filling containing functional ingredients that are released from the casing before the casing has entirely dissolved
Inventor: RIVIER VINCENT
IPC: A23G3/00
Filed: 2001-04-02
Abstract: A confectionery product having at least one functional ingredient comprises a casing and a filing enclosed within the casing wherein the filling comprises at least one confectionary material having properties that confer to the filling a perceivable effect when the filling is released in the mouth. The casing is capable of forming release means upon the action of the saliva in the mouth which acts to liberate the filling out of the casing, The release means comprises at least one hole and//or zone of reduced thickness provided in the casing which is capable of forming at least one outside passage communicating with the filling. The confectionery material has dissolution properties effective to act together with the release means so as to enable the casing to be left substantially as an empty shell before it has entirely dissolved in the mouth. The confectionary product can be used in a method for improving consumer acceptance of a confectionary product wherein a sensory agent is incorporated into the product to produce perceivable sensory effect in the consumer's mouth indicative of functional release. Preferably the confectionery material of filling is chosen to confer a liquid and cooling effect when released in the mouth and is preferably a polyol selected form xylitol, erythritol or sorbitol.
Patent NZ-523674-A (NZ)
Title: Clamp plate for casting mold sidewalls, with interlocking members projecting in opposite directions at ends of plate, and clamp magnet
Inventor: VAPPULA KARI
IPC: B28B7/00
Filed: 2003-01-16
Abstract: Disclosed is an interlocking plate to connect two adjacent sidewalls of a concrete casting mold. Plate element 1 has at both of its ends locking members 2,2' adapted to rest against the exterior sides of the casting mold sidewalls. The members 2,2' are aligned to project in opposite directions from the end of plate 1. At least one clamp magnet 3,3' is also provided.
Patent NZ-527649-A (NZ)
Title: Combination of an iodopropynyl derivative with a ketone acid or its salt and/or with an aromatic carboxylic acid or its salt
Inventor: LUTZ PATRICK JAY
IPC: A01N25/22
Filed: 2002-02-28
Abstract: Disclosed is a composition including: (a) an iodopropynyl butyl carbamate; and (b) (i) dehydroacetic acid or a salt thereof, (ii) a salicylic acid or a salt thereof, or (iii) a mixture thereof. Further disclosed is the use of the composition in a non-therapeutic method of inhibiting the growth of microorganisms.
Patent NZ-529126-A (NZ)
Title: Use of neublastin polypeptides for treating allodynia, hyperalgesic pain and phantom pain
Inventor: SAH DINAH W Y
IPC: A61P25/02
Filed: 2002-02-28
Abstract: Disclosed is the use of a neublastin polypeptide in the preparation of a pharmaceutical composition for treating, preventing, or delaying neuropathic pain, wherein the neuropathic pain is allodynia, hyperalgesic pain, or phantom pain.
Patent NZ-529839-A (NZ)
Title: Materials and methods for the modification of plant lignin content
Inventor: BLOKSBERG LEONARD NATHAN
IPC: C12N9/88
Filed: 1999-10-06
Abstract: An isolated polynucleotide encoding ferulate-5-hydroxylase (F5H), isolated primers for amplifying said polynucleotide, a kit comprising a plurality of said primers, a genetic construct comprising said polynucleotide, a transformed cell transformed by said genetic construct are disclosed. Also described is a method for modulating plant lignin content, lignin composition and lignin structure by stably incorporating into the genome of a plant said polynucleotide, and a method for producing a plant with altered lignin content, composition and structure.
Patent NZ-530643-A (NZ)
Title: Moisture barrier in foods
Inventor: BASTIAANS JOHANNES ADRIANUS HE
IPC: A21D13/08
Filed: 2002-07-19
Abstract: A composite food comprising a particulate moisture-sensitive food ingredient selected from nuts, cereals, fruit, vegetables, chocolate, pasta and mixtures thereof, in a water-containing edible or drinkable medium, the ingredient being coated with a continuous fat phase in which 1-15% (m/m) water insoluble and fat insoluble particles having an average diameter of 0.05-100ìm are present. A process for coating a food ingredient selected from nuts, cereals, fruit, vegetables, chocolate, pasta and mixtures thereof, comprises applying a dispersion of 1-15% (m/m) water-insoluble and fat-insoluble particles having an average particle diameter of 0.05-100ìm in a fat to the food ingredient at a temperature above the melting point of the fat and solidifying the fat rapidly after application. Also disclosed is a coated food component consisting of a moisture-sensitive food-containing core selected from nut, cereals, fruit, vegetables, chocolate, pasta and mixtures thereof, and a moisture-resistant coating having a thickness of 0.1-5mm, the coating containing 1-15%(m/m), preferably 3-10 wt.% of silica or silicates having an average particle diameter of 0.05-100ìm, the coating not containing the moisture sensitive food.
Patent NZ-535985-A (NZ)
Title: Substituted benzazoles and use thereof as RAF kinase inhibitors
Inventor: RENHOWE PAUL A
IPC: C07D453/02
Filed: 2003-03-31
Abstract: Disclosed are benzazole compounds of formula I, compositions and methods of inhibition of Raf kinase activity. Composition of these compounds may be used either alone or in combination with at least one additional agent for the treatment of a Raf kinase mediated disorder, such as cancer.
Patent NZ-539899-A (NZ)
Title: Cleaning implement with antimicrobial handle, used for cleaning hard surfaces
Inventor: MINKLER DOUGLAS J
IPC: A47L25/00
Filed: 2005-05-09
Abstract: Disclosed is a cleaning implement with a handle, the implement being used for cleaning hard surfaces, wherein the cleaning handle has an antimicrobial surface.
Patent NZ-542402-A (NZ)
Title: Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof
Inventor: HIMMELSBACH FRANK
IPC: A61P35/00
Filed: 2004-02-14
Abstract: Bicyclic heterocycles of general formula (I) are disclosed, wherein Ra, Rb, Rc, Rd, Re, and X have the definitions indicated in the specification, the tautomers, stereoisomers, mixtures, and salts thereof, especially the physiologically acceptable salts thereof containing inorganic or organic acids having valuable pharmaceutical properties, especially an inhibiting effect on signal transduction mediated by tyrosine kinases, The disclosure also relates to the use of these compounds for treating diseases, especially cancer diseases and benign prostatic hyperplasia (BPH), diseases of the lungs and respiratory tract, and the production of these compounds and pharmaceutical compositions thereof.
Patent NZ-544071-A (NZ)
Title: Module and frame for cable entries
Inventor: KREUTZ TOMAS
IPC: H02G3/22
Filed: 2004-06-14
Abstract: The present invention concerns a module (3) and a frame (1) for cable entries, pipe penetrations into a variety of objects such as buildings, ships bulkheads and cabinets. The module (3) has end parts (7) and middle parts (8) adaptable to receive flat cables (6) or the like having an elongated cross section. The end parts (7) may be identical to parts forming a module (2) for receiving cables, pipes etc. having a circular cross section. The frame (1) is to receive one or more of said module (3).